Current status + progress
COVID-19 and vaccinations
Vaccines for COVID-19 are critical tools for helping to bring the pandemic under control when combined with effective testing, treatment and existing prevention measures. Vaccinating the world against this disease is the largest vaccine procurement and supply operation in history – and UNICEF is leading this effort on behalf of the Global COVAX Facility.
UNICEF and partners are working to ensure equitable access to 2 billion doses of the COVID-19 vaccine by the end of 2021.
UNICEF’s interactive COVID-19 market dashboard provides a regularly updated overview of the global research and development pipeline, the projected production capacity, publicly announced bilateral and multilateral supply agreements, as well as reported price points.
- What you need to know about the COVID-19 vaccine
- What parents need to know about the COVID-19 vaccine
- Resources for managing the deployment, implementation and monitoring of COVID-19 vaccines
- How UNICEF is working to ensure global equitable access to COVID-19 vaccines
COVID-19 has reduced access to life-saving vaccines to combat diseases such as measles and polio
Immunization is one of the most cost-effective public health interventions to date, averting an estimated 2 to 3 million deaths every year.
Yet even before the coronavirus pandemic, more than 13 million children didn’t receive any vaccines and at least 20 million children below the age of one did not receive the recommended vaccines against measles, polio, and other preventable diseases.
Now, COVID-19 is leaving many of the world’s most marginalised children without access to immunization. Unless the COVID-19 vaccine response is bold enough, there is a risk for lasting negative impact on routine immunization coverage. Given the current disruptions, this could create pathways to disastrous outbreaks in 2021 and well beyond. Access our COVID-19 hub for more information.